Skip to main content

Advertisement

SpringerLink
Log in

Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence

  • Review
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rohan TE, Kandel RA (2002) Breast. In: Franco EL, Rohan TE (eds) Cancer precursors: epidemiology, detection, and prevention. Springer-Verlag, New York, 232–248

    Google Scholar 

  2. Soini I, Aine R, Lauslahti K, Hakama M (1981) Independent risk factors of benign and malignant breast lesions. Am J Epidemiol 114:507–514

    PubMed  CAS  Google Scholar 

  3. Lakhani SR (1999) The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187:272–278

    Article  PubMed  CAS  Google Scholar 

  4. Miller AB, Soule HD, Tait L, Pauley RJ, Wolman SR, Dawson PJ, Heppner GH (1993) Xenograph model of progressive human proliferative breast disease. J Natl Cancer Inst 85:1725–1732

    Article  PubMed  CAS  Google Scholar 

  5. Davies BR, Platt-Higgins AM, Schmidt G Rudland PS (1999) Development of hyperplasias, preneoplasias, and mammary tumors in mmtv-c-erbb-2 and mmtv-tffα transgenic rats. Am J Pathol 155:303–314

    PubMed  CAS  Google Scholar 

  6. Li Y, Hively WP, Varmus HE (2000) Use of mmtv-wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19:1002–1009

    Article  PubMed  CAS  Google Scholar 

  7. Schnitt SJ (2003) Benign breast disease and breast cancer risk. Am J Surg Pathol 27:836–841

    Article  PubMed  Google Scholar 

  8. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton III LJ and Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237

    Article  PubMed  CAS  Google Scholar 

  9. Worsham MJ, Abrams J, Raju U, Kapke A, Lu M, Cheng J, Mott D, Wolman SR (2007) Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J 13:115–121

    Article  PubMed  Google Scholar 

  10. Marshall LM, Hunter DJ, Connolly JL, Schnitt SK, Byrne C, London SJ, Colditz G (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297–301

    PubMed  CAS  Google Scholar 

  11. Wang DY, Fentiman IS (1985) Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 6:5–36

    Article  PubMed  CAS  Google Scholar 

  12. Rohan TE, Hartwick W, Miller AB, Kandel RA (1998) Immunohistochemical detection of c-erbb-2 and p53 proteins in benign breast disease and breast cancer risk. J Natl Cancer Inst 90:1262–1269

    Article  PubMed  CAS  Google Scholar 

  13. Franz VK, Pickren JW, Melcher GW, Auchincloss H Jr (1951) Incidence of chronic cystic disease in so-called normal breasts. Cancer 4:762–783

    Article  Google Scholar 

  14. Sloss PT, Bennett WA, Clagett OT (1957) Incidence in normal breasts of features associated with chronic cystic mastitis. Am J Pathol 33:1181–1191

    PubMed  CAS  Google Scholar 

  15. Sandison AT (1962) An autopsy study of the adult human breast. US GPO, Washington, DC

    Google Scholar 

  16. Humphrey LJ, Swerdlow M (1966) Histologic changes in clinically normal breasts at postmortem examination. Arch Surg 92:192–193

    PubMed  CAS  Google Scholar 

  17. Kramer WM, Rush Jr BF (1973) Mammary duct proliferation in the elderly. A histopathologic study. Cancer 31:130–137

    Article  PubMed  CAS  Google Scholar 

  18. Sasano N, Tateno H, Stemmerman GN (1978) Volume and hyperplastic lesions of breasts of japanese women in hawaii and japan. Prev Med 7:196–204

    Article  PubMed  CAS  Google Scholar 

  19. Nielson M, Jenson J, Anderson J (1984) Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women. Cancer 54:612–615

    Article  Google Scholar 

  20. Alpers CE, Wellings SR (1985) The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 16:796–807

    Article  PubMed  CAS  Google Scholar 

  21. Bhathal PS, Brown RW, Lesueur GC, Russell IS (1985) Frequency of benign and malignant breast lesions in 207 consecutive autopsies in australian women. Br J Cancer 51:271–278

    PubMed  CAS  Google Scholar 

  22. Nielson M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA (1987) Breast cancer and atypia among young and middle aged women: A study of 110 medicolegal autopsies. Br J Cancer 56:814–819

    Google Scholar 

  23. Sarnelli R, Squartini F (1991) Fibrocstic condition and "at risk" lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol 18:271–279

    PubMed  CAS  Google Scholar 

  24. Ory H, Cole P, MacMahon B, Hoover R (1976) Oral contraeptive and reduced risk of benign breast disease. N Engl J Med 249:419–422

    Article  Google Scholar 

  25. Cole P, Elwood JM, Kaplan SD (1978) Incidence rates and risk of factors of benign breast neoplasms. Am J Epidemiol 108:112–120

    PubMed  CAS  Google Scholar 

  26. Brinton LA, Vessey MP, Flavel R, Yeates D (1981) Risk factors for benign breast disease. Am J Epidemiol 113:203–214

    PubMed  CAS  Google Scholar 

  27. Fleming NT, Armstrong BK, Sheiner HJ (1982) The comparative epidemiology of benign breast lumps and breast cancer in western australia. Int J Cancer 30:147–152

    Article  PubMed  CAS  Google Scholar 

  28. Heinemann K, Thiel C, Mohner S, Lewis MA, Raff T, Kuhl-Habich D, Heinemann LAJ (2003) Benign gynecological tumors: Estimate incidence results of the german gohort study on women’s health. Eur J Obstet Gynecol Reprod Biol 107:78–80

    Article  PubMed  Google Scholar 

  29. Cook MG, Rohan TE (1985) The patho-epidemiology of benign proliferative epithelial disorders of the female breast. J Path 146:1–15

    Article  PubMed  CAS  Google Scholar 

  30. Lance LL (1981) Risk factors for benign breast disease. Am J Epidemiol 114:606–607

    PubMed  CAS  Google Scholar 

  31. Parazzini F, La Vecchia C, Franceschi S, Decarli A, Gallus G, Regallo M, Liberati A, Tognoni G (1991) Risk factors for pathologically confirmed benign breast disease. Am J Epidemiol 120:115–122

    Google Scholar 

  32. Parazzini F, Perraroni M, La Vecchia C, Baron JA, Levi F, Franceschi S, Decarli A (1991) Smoking habits and risk of benign breast disease. Int J Epidemiol 20:430–434

    Article  PubMed  CAS  Google Scholar 

  33. Berkowitz GS, Kelsey JL, LiVolsi VA, Holford TR, Merino MJ, Ort S, O’Connor TZ, White C (1985) Risk factors for fibrocystic breast disease and its histopathologic components. J Natl Cancer Inst 75:43–50

    PubMed  CAS  Google Scholar 

  34. Pastides H, Kelsey JL, Holford TR, LiVolsi VA (1985) An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia. Am J Epidemiol 121:440–447

    PubMed  CAS  Google Scholar 

  35. Bright RA, Morrison AS, Brisson J, Burstein NA, Sadowsky NL, Kopans DB, Meyer JE (1989) Histologic and mammographic specificity of risk factors for benign breast disease. Cancer 64:653–657

    Article  PubMed  CAS  Google Scholar 

  36. Rohan TE, Cook MG (1989) Alcohol consumption and risk of benign proliferative epithelial disorders of the breast in women. Int J Cancer 43:631–636

    Article  PubMed  CAS  Google Scholar 

  37. Rohan TE, Cook MG, Baron JA (1989) Cigarette smoking and benign proliferative epithelial disorders of the breast in women: A case–control study. J Epidemiol Community Health 43:362–368

    Article  PubMed  CAS  Google Scholar 

  38. Ingram DM, Nottage E, Ng S, Sparrow L, Roberts A, Willcox D (1989) Obesity and breast disease. The role of the female sex hormone. Cancer 64:1049–1053

    CAS  Google Scholar 

  39. Ingram DM, Nottage E, Roberts T (1991) The role of diet in the development of breast cancer: A case–control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast. Br J Cancer 64:187–191

    PubMed  CAS  Google Scholar 

  40. London SJ, Stein EA, Henderson IC, Stampfer MJ, Wood WC, Remine S, Dmochowski JR, Robert NJ, Willett WC (1992) Carotenoids, retinol, and vitamin e and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control 3:503–512

    Article  PubMed  CAS  Google Scholar 

  41. Minami Y, Ohuchi N, Taeda y, Fukao A, Hisamichi S (1998) Risk factors for benign breast disease according to histopathological type: Comparisons with risk factors for breast disease. Jpn J Cancer Res 89:116–123

    PubMed  CAS  Google Scholar 

  42. Hsieh CC, Walker AM, Trapido EJ, Crosson AW, MacMahon B (1984) Age at first birth and breast atypia. Int J Cancer 33:309–312

    Article  PubMed  CAS  Google Scholar 

  43. Rohan TE, L’Abbe KA Cook MG (1992) Oral contraceptives and risk of benign proliferative epithelial disorders of the breast. Int J Cancer 50:891–894

    Article  PubMed  CAS  Google Scholar 

  44. LiVolsi VA, Stadel BV, Kelsey JL, Holford TR, White C (1978) Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia. N Engl J Med 299:381–385

    Article  PubMed  CAS  Google Scholar 

  45. Pastides H, Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Goldenberg IS (1983) Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology. J Natl Cancer Inst 71:5–9

    PubMed  CAS  Google Scholar 

  46. Berkowitz GS, Kelsey JL, Merino MJ, Holford TR, Hildreth NG, Ort S, O’Connor TZ, White C (1984) Exogenous hormone use and fibrocystic breast disease by histopathologic component. Int J Cancer 34:443–449

    Article  PubMed  CAS  Google Scholar 

  47. Rohan TE, Miller AB (1999) Hormone replacement therapy and risk of benign proliferative epithelial disorders of the breast. Eur J Epidemiol 8:123–130

    CAS  Google Scholar 

  48. Rohan TE, Cook MG, Potter JD, McMichael AJ (1990) A case–control study of diet and benign proliferative epithelial disorders of the breast. Cancer Res 50:3176–3181

    PubMed  CAS  Google Scholar 

  49. London SJ, Sacks FM, Stampfer MJ, Henderson AC, Maclure M, Tomita A, Wood WC, Remine S, Robert NJ, Dmochowski JR, Willett WC (1993) Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst 85:785–793

    Article  PubMed  CAS  Google Scholar 

  50. Baghurst PA, Rohan TE (1995) Dietary fiber and risk of benign proliferative epithelial disorders of the breast. Int J Cancer 63:481–485

    Article  PubMed  CAS  Google Scholar 

  51. Lubin F, Wax Y, Ron E, Black M, Chetrit A, Rosen N, Alfandary E, Modan B (1989) Nutritional factors associated with benign breast disease etiology: A case–control study. Am J Clin Nutr 50:551–556

    PubMed  CAS  Google Scholar 

  52. Friedenreich CM, Rohan TE (1994) Recreational physical activity and risk of benign proliferative epithelial disorders of the breast in women. Eur J Cancer Prev 3:465–471

    Article  PubMed  CAS  Google Scholar 

  53. Wu C, Ray RM, Lin MG, Neilann DLG, Korner NK, Nelson ZC, Lampe JW, Hu YW, Shannon J, Stalsberg H, Li W, Fitzgibbons PL, Porter P, Patterson RE, Satia JA, Thomas DB (2004) A case–control study of risk factors for fibrocystic breast conditions. Shanghai nutrition and breast disease study, china, 1995–2000. Am J Epidemiol 160:945–960

    Article  PubMed  Google Scholar 

  54. Friedenreich CM, Bryant HE, Alexander F, Hugh J, Danyluk J, Page DL (2000) Risk factors for benign proliferative breast disease. Int J Epidemiol 29:637–644

    Article  PubMed  CAS  Google Scholar 

  55. Rohan TE, Jain M, Miller AB (1998) A case–cohort study of diet and risk of benign proliferative epithelial disorders of the breast (canada). Cancer Causes Control 9:19–27

    Article  PubMed  CAS  Google Scholar 

  56. Rohan TE, Miller AB (1999) A cohort study of oral contraceptive use and risk of benign breast disease. Int J Cancer 82:191–196

    Article  PubMed  CAS  Google Scholar 

  57. Rohan TE (1999) Cigarette smoking and risk of benign proliferative epithelial disorders of the breast. Eur J Epidemiol 15:529–535

    Article  PubMed  CAS  Google Scholar 

  58. Rohan TE, Jain M, Miller AB (1998) Alcohol consumption and risk of benign proliferative epithelial disorders of the breast: A case–cohort study. Public Health Nutr 1:139–145

    Article  PubMed  CAS  Google Scholar 

  59. Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs TW, Baer HJ, Willett WC, Colditz G (2004) A prospective study of diet and benign breast disease. Cancer Epidemiol Biomarkers Prev 13:1106–1113

    PubMed  Google Scholar 

  60. Cui Y, Page DL, Chlebowski RT, Beresford SA, Hendrix SL, Lane DS, Rohan TE (2007) Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast. Int J Cancer online advance of print, http://www3.interscience.wiley.com/cgi-bin/fulltext/114274175/HTMLSTART

  61. Cui Y, Page DL, Chlebowski RT, Hsia J, Hubbell FA, Johnson KC, Rohan TE (2007) Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the women’s health initiative. Cancer Causes Control 18:431–438

    Article  PubMed  Google Scholar 

  62. Hislop TG, Band PR, Deschamps M, Ng V, Coldman AJ, Worth AJ, Labo T (1990) Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol 131:263–270

    PubMed  CAS  Google Scholar 

  63. Hankinson SE, Hunter DJ (2002) Breast cancer. In: Adami HO, Hunter DJ, Tricholopoulos D (eds) Textbook of cancer epidemiology. Oxford, Oxford University Press, pp 301–339

    Google Scholar 

  64. World Cancer Research Fund and American Institute for Cancer Research (1997) Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC

  65. IARC (2002) Handbooks on cancer prevention, weight control and physical activity. Lyon, IARC Press

    Google Scholar 

  66. . Huang Z, Hankinson SE, Colditz G, Stampfer MJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC (1997) Dual effects of weight and weight gain on breast cancer. JAMA 278:1407–1411

    Article  PubMed  CAS  Google Scholar 

  67. Hunter DJ, Willett WC (1993) Diet, body size, and breast cancer. Epidemiol Rev 15:110–132

    PubMed  CAS  Google Scholar 

  68. Singletary SE (2003) Rating the risk factors for breast cancer. Ann Surg 237:474–482

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health and Nutrition Sciences, Montclair State University, 1 Normal Ave, University Hall, Room 4171, Montclair, NJ, 07043, USA

    Stephanie A. Navarro Silvera

  2. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA

    Thomas E. Rohan

Authors
  1. Stephanie A. Navarro Silvera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas E. Rohan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephanie A. Navarro Silvera.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silvera, S.A.N., Rohan, T.E. Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence. Breast Cancer Res Treat 110, 397–409 (2008). https://doi.org/10.1007/s10549-007-9740-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-007-9740-3

Keywords

Search

Navigation